Human COVID Vaccine Trials Begin

Human COVID Vaccine Trials Begin

(NewsReady.com) – Researchers are scrambling to develop a cure for COVID-19 as quickly as possible to mitigate any further damage caused by the pandemic. Johnson & Johnson (J&J) made a deal with the government to produce one billion doses of a vaccine whenever there is one. Currently, J&J is working on its own potential vaccination that may be ready for human testing later this year.

Another company has begun testing a potential vaccine, as well. Inovio Pharmaceuticals is now doing live testing on a small group of volunteers located in Philadelphia, Pennsylvania and Kansas City, Missouri.

Volunteers in the Inovio trial will get two vaccine doses with four weeks between each dose. The company expects to have early data regarding the safety of INO-4800 by late summer. If the results look good, they’ll start another study to determine its effectiveness against the coronavirus.

If all goes well, the biotech company also plans to manufacture one million doses by the end of the year. Inovio Pharmaceuticals received funding from the Bill and Melinda Gates Foundation, which, in part, makes this early trial run possible. Still, any company that comes up with a successful vaccine will also have to deal with massive demand and must ramp up its manufacturing capabilities.

~Daily News for Busy People!

Copyright 2020, NewsReady.com

2 COMMENTS

  1. Look up the Tolstoy length tome of past and pending lawsuits against Johnson & Johnson.
    Anyone who lets these professional poisoners near their bloodstream is taking a greater risk than with CV19.
    Be prepared to be labeled an “anti vaxxer conspiwacy theowist” if you do not Submit.

    Vaccination Liberation.

Comments are closed.